Suppr超能文献

帕金森病中的焦虑症

Anxiety disorders in Parkinson's disease.

作者信息

Richard Irene H

机构信息

University of Rochester School of Medicine and Dentistry Rochester, New York, USA.

出版信息

Adv Neurol. 2005;96:42-55.

Abstract

Anxiety disorders frequently occur in association with PD and may be important causes of morbidity. Actual prevalence rates are uncertain, but estimates suggest that up to 40% of patients with PD experience substantial anxiety. This percentage is greater than expected, particularly for an elderly population. In addition, the age at onset of anxiety in PD (and particularly panic disorder) is later than would be expected from current information regarding the natural course of anxiety disorders. Virtually all of the types of anxiety disorders have been described in PD, but panic disorder, GAD, and social phobia appear to be the ones most commonly encountered. Although most patients with motor fluctuations experience greater anxiety during the "off" phase, this is not a universal phenomenon. Anxiety frequently develops before the motor features do, suggesting that anxiety may not represent psychological and social difficulties in adapting to the illness but rather may be linked to specific neurobiologic processes that occur in PD. Most evidence points to disturbances in central noradrenergic systems, but other neurotransmitters (e.g., serotonin, dopamine) may be involved as well. Studies suggest that right hemispheric disturbances may be particularly important for the genesis of anxiety, especially panic and OCD. Whether antiparkinsonian medications themselves contribute to anxiety needs clarification. Anxiety and depression frequently coexist in PD. It remains to be determined whether anxiety in patients with PD reflects one of the following pathologies: (a) an underlying depressive mood disorder, (b) a particular subtype of depression (atypical depression, anxious or agitated depression), or (c) an independent psychiatric disturbance. The relationship between anxiety and dementia in PD is not clear, but current evidence suggests that cognitive dysfunction is not related to the presence of anxiety symptoms in this disorder. The optimal pharmacologic treatment for anxiety in patients with PD has not been established, nor has the effect of PD surgery on anxiety symptoms.

摘要

焦虑症常与帕金森病(PD)并发,可能是发病的重要原因。实际患病率尚不确定,但估计表明,高达40%的PD患者有明显焦虑。这个比例高于预期,尤其是对于老年人群体。此外,PD中焦虑症的发病年龄(尤其是惊恐障碍)比目前关于焦虑症自然病程的信息所预期的要晚。几乎所有类型的焦虑症都在PD中有所描述,但惊恐障碍、广泛性焦虑症(GAD)和社交恐惧症似乎是最常见的。虽然大多数有运动波动的患者在“关”期焦虑更严重,但这并非普遍现象。焦虑症常常在运动症状出现之前就已出现,这表明焦虑症可能并非代表适应疾病过程中的心理和社会困难,而是可能与PD中发生的特定神经生物学过程有关。大多数证据指向中枢去甲肾上腺素能系统紊乱,但其他神经递质(如血清素、多巴胺)可能也参与其中。研究表明,右半球功能紊乱可能对焦虑症的发生尤为重要,尤其是惊恐障碍和强迫症。抗帕金森病药物本身是否导致焦虑症尚需明确。焦虑症和抑郁症在PD中常同时存在。PD患者的焦虑症是否反映以下病理情况之一仍有待确定:(a)潜在的抑郁情绪障碍,(b)抑郁症的特定亚型(非典型抑郁症、焦虑或激越性抑郁症),或(c)独立的精神障碍。PD中焦虑症与痴呆症之间的关系尚不清楚,但目前证据表明,认知功能障碍与该疾病中焦虑症状的存在无关。PD患者焦虑症的最佳药物治疗方法尚未确立,PD手术对焦虑症状的影响也未明确。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验